Dr. Michael Scott Plisco MD, FCCP

Recommended Articles

• What Are the Signs and Symptoms of AIDS?

  Acquired immunodeficiency syndrome, or AIDS, is a serious secondary immunodeficiency disorder. AIDS is caused by human immunodeficiency virus (HIV). There is progressive destruction of cell-mediated (T cell) immunity. Also, both conditions are characterized by subsequent effects on humoral immunity...

• Former Pro Athlete Sells Medal to Give Teen Soccer Fan Lung Transplant

  Mo Johnston, former star athlete as part of both the Rangers and the Celtics has decided he wants to give back. He has decided to sell his league medal in order to raise money so a teen with cystic fibrosis could receive a lung transplant that has become crucial to his health.Background on...

• COPD: Nicotine Replacement Therapy

  Cessation of Smoking and Medication UseThe first goal for patients with COPD who smoke is to get the patient to quit smoking. When a patient with COPD stops smoking, breathing will not be as difficult as it has been while the patient was smoking. Moreover, even if the patient is diligently taking...

• What Can Cause Shortness of Breath (Dyspnea)?

  Shortness of breath is defined as the feeling of inability to breathe normally, hence producing a troublesome sensation. Such breathlessness is a distinct issue in every affected individual. Typically, if in an event of modest labor or any unexpected situation leads to a shortness of breath, it is...

• How Cystic Fibrosis Progresses in Patients

  CF is an inherited disease that progresses throughout a patient’s life. Progression can occur when the thick and sticky mucus that accumulates within the body triggers inflammation and scarring in multiple different organs, thus leading to permanent damage. Unfortunately, many CF symptoms and...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...